mynth
← DATABASE
05/2018

THE CARLYLE GROUP takes majority stake in HGH SYSTÈMES INFRAROUGES

FRANCE Hardware & Electronics / Electronic Components / Sensors & Optics REV 10M - 30M EUR

Context

The Carlyle Group has announced the acquisition of a majority stake in HGH Systèmes Infrarouges through its Carlyle Europe Technology Partners III fund, as part of a structured control transaction. This move is part of a broader strategy to strengthen the fund's position in high-value-added electro-optical and infrared technologies. Beyond the transaction's structuring, the partnership aims to accelerate HGH's international growth by leveraging Carlyle's investment capabilities and industrial network. The goal is to support the company's expansion in the defense, security, and critical infrastructure markets, as well as in applications related to emerging asymmetric threats. To achieve this, Carlyle plans to support HGH's technological and commercial development, with increased investments in R&D and a focus on expanding the company's infrared surveillance and image analysis solutions. The completion of the transaction remains subject to customary regulatory conditions and the obtaining of necessary approvals. This acquisition is part of a larger strategy to build specialized technology platforms focused on advanced surveillance systems and optronic solutions.

HGH SYSTÈMES INFRAROUGES, which reported an EBITDA margin of in 2018, is valued in this transaction at an EV/EBITDA multiple of , a level to compare with the average currently observed in the TMT (Tech, Media, Telecom) sector (15.1x).

-> Deep-dive in TMT (Tech, Media, Telecom) market trends

Target

HGH Systèmes Infrarouges is a French company founded in 1982, specializing in the design of electro-optical and infrared systems for the defense, security, and industrial markets. The company develops advanced surveillance and detection solutions based on high-precision infrared sensors, combined with proprietary software that enables real-time data analysis and processing. Over time, HGH has positioned itself as a leader in long-range surveillance technologies, particularly for threat detection, sensitive area protection, and critical infrastructure monitoring. Its systems are used in a variety of applications, including air defense, drone detection, maritime surveillance, border security, and strategic site protection. HGH boasts a strongly differentiated technology portfolio, built on a foundation of patents and significant in-house R&D capabilities. The company's business model is characterized by high technological intensity, combining infrared optics, embedded software, and artificial intelligence to enhance object and threat detection and classification capabilities.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2018
2017

Other operations with HGH SYSTÈMES INFRAROUGES

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
DateAcquirerTargetCountrySector
06/2026THEON INTERNATIONALHGH SYSTÈMES INFRAROUGESFRANCESensors & Optics

REFERENCES

Revenue range: 10M - 30M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of HGH SYSTÈMES INFRAROUGES by THE CARLYLE GROUP are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Target: hgh systèmes infrarouges

Acquirer: the carlyle group